GJ
Gagan Jot Singh
About Gagan Jot Singh
Gagan Jot Singh has 14 years in corporate governance. Holds Director role. Currently with 4 companies, including Atomikon Sciences Private Limited and Avanscure Lifesciences Private Limited. Formerly with 1 company, such as Cliniv Health Tech Llp. Engaged in General Business, Technology. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Atomikon Sciences Private Limited
U15545KA2019PTC124380
|
Director | 16 May 2019 | 2019 | Active |
Avanscure Lifesciences Private Limited
U74120UP2012PTC050329
|
Director | 07 May 2012 | 2012 | Active |
Elevatoz Loyalty Private Limited
U74999KA2018PTC112520
|
Director | 26 Apr 2018 | 2018 | Active |
Avansdose Pharmatech Private Limited
U74999TG2017PTC115497
|
Director | 27 Feb 2017 | 2017 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Cliniv Health Tech Llp
AAS-9521
|
Designated Partner | 19 Jul 2020 | 2020 | Converted And Dissolved |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Gagan Jot Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gagan Jot Singh
Gagan Jot Singh has 14 years in corporate governance. Holds Director role. Currently with 4 companies, including Atomikon Sciences Private Limited and Avanscure Lifesciences Private Limited. Formerly with 1 company, such as Cliniv Health Tech Llp. Engaged in General Business, Technology. Contributes to corporate operations.
Gagan Jot Singh is associated with 4 companies as Director.
Gagan Jot Singh has expertise in General Business, Technology.
Gagan Jot Singh has 14 years in corporate governance.